{"id":"cannabidiol-oral-oil","safety":{"commonSideEffects":[{"rate":null,"effect":"Somnolence"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Decreased appetite"},{"rate":null,"effect":"Elevated liver enzymes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cannabidiol (CBD) is a non-intoxicating cannabinoid that interacts with multiple molecular targets including serotonin receptors (5-HT1A), vanilloid receptors (TRPV1), and glycine receptors, while also modulating endocannabinoid tone indirectly. It exhibits anti-inflammatory, antioxidant, and neuroprotective properties through these diverse mechanisms. The exact therapeutic mechanism varies by indication but generally involves reduction of neuroinflammation and modulation of neural signaling.","oneSentence":"Cannabidiol modulates endocannabinoid signaling and multiple other pathways to produce anxiolytic, anti-inflammatory, and neuroprotective effects.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:29:42.934Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seizure disorders (Dravet syndrome, Lennox-Gastaut syndrome)"},{"name":"Anxiety disorders"},{"name":"Epilepsy"}]},"trialDetails":[{"nctId":"NCT07459920","phase":"PHASE2","title":"Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2026-04-01","conditions":"Advanced Malignant Solid Tumor","enrollment":156},{"nctId":"NCT06333041","phase":"PHASE2, PHASE3","title":"Study of Cannabidiol in Sanfilippo Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2026-03-15","conditions":"Sanfilippo Syndrome, Mucopolysaccharidosis III","enrollment":35},{"nctId":"NCT07148206","phase":"PHASE3","title":"Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial","status":"NOT_YET_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-05","conditions":"Opioid Use Disorder","enrollment":40},{"nctId":"NCT05066308","phase":"PHASE2","title":"Cannabidiol for Reduction of Brain Neuroinflammation","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-01-04","conditions":"Back Pain, Depressive Symptoms","enrollment":80},{"nctId":"NCT07359976","phase":"NA","title":"Pharmacokinetic Evaluation of a Natural CBD Extract","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-01-04","conditions":"Pharmacokinetics of CBD Extract, Oral and Topical Administrations","enrollment":20},{"nctId":"NCT07298408","phase":"PHASE1, PHASE2","title":"Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Florida A&M University","startDate":"2026-01-02","conditions":"Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies","enrollment":20},{"nctId":"NCT06261489","phase":"PHASE2","title":"Cannabis (THC vs. CBD) in Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Calgary","startDate":"2025-12-05","conditions":"Multiple Sclerosis","enrollment":30},{"nctId":"NCT05351905","phase":"NA","title":"Improving Pain Disability With the Use of Oral Cannabinoids","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2022-11-22","conditions":"Chronic Pain, Opioid Use, Cannabis","enrollment":51},{"nctId":"NCT05445804","phase":"PHASE1","title":"Oral Cannabidiol for Tobacco Cessation","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-11-01","conditions":"Tobacco Use, Tobacco Smoking, Tobacco Dependence","enrollment":50},{"nctId":"NCT05644262","phase":"PHASE2","title":"Life's End Benefits of cannaBidiol and tetrahYdrocannabinol","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2023-12-18","conditions":"Agitation, Dementia","enrollment":120},{"nctId":"NCT05632627","phase":"PHASE2","title":"Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-04-11","conditions":"Brain Injuries, Traumatic","enrollment":43},{"nctId":"NCT05649059","phase":"PHASE4","title":"Investigating the Effects of Cannabidiol on Social Anxiety Disorder","status":"RECRUITING","sponsor":"Massachusetts Institute of Technology","startDate":"2025-07-10","conditions":"Phobia, Social","enrollment":50},{"nctId":"NCT06787118","phase":"PHASE3","title":"Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2025-12","conditions":"Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III","enrollment":130},{"nctId":"NCT07199218","phase":"PHASE2","title":"Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism","status":"RECRUITING","sponsor":"Bazelet Nehushtan LtD.","startDate":"2025-10-05","conditions":"Autism, Autism Spectrum Disorder","enrollment":78},{"nctId":"NCT04821856","phase":"PHASE2","title":"Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2021-05-11","conditions":"Intellectual Disability, Child Behavior Problem","enrollment":132},{"nctId":"NCT04721691","phase":"PHASE1","title":"Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2021-03-10","conditions":"Electrical Status Epilepticus of Slow-Wave Sleep","enrollment":16},{"nctId":"NCT04044729","phase":"EARLY_PHASE1","title":"Mechanisms of CBD for Chronic Pain","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-03-16","conditions":"Chronic Pain","enrollment":24},{"nctId":"NCT04745026","phase":"PHASE2","title":"Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2021-05-31","conditions":"Autism Spectrum Disorder","enrollment":103},{"nctId":"NCT03825965","phase":"PHASE3","title":"Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT","status":"COMPLETED","sponsor":"McMaster University","startDate":"2023-05-03","conditions":"Knee Osteoarthritis","enrollment":39},{"nctId":"NCT04428203","phase":"PHASE1","title":"Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer","status":"COMPLETED","sponsor":"Zin W Myint","startDate":"2020-08-03","conditions":"Prostate Cancer Recurrent, Prostate Cancer, Prostate Adenocarcinoma","enrollment":21},{"nctId":"NCT05159830","phase":"PHASE2","title":"Cannabidiol for Reducing Drinking in Alcohol Use Disorder","status":"RECRUITING","sponsor":"Hôpital le Vinatier","startDate":"2024-10-25","conditions":"Alcohol Use Disorder","enrollment":76},{"nctId":"NCT05618756","phase":"NA","title":"CBD, Nutrient Metabolism and Energy Intake","status":"COMPLETED","sponsor":"Loughborough University","startDate":"2021-09-30","conditions":"Glucose Metabolism Disorders (Including Diabetes Mellitus), Lipid Metabolism Disorders, Appetitive Behavior","enrollment":15},{"nctId":"NCT06692933","phase":"EARLY_PHASE1","title":"Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel","status":"RECRUITING","sponsor":"Washington State University","startDate":"2024-06-20","conditions":"Interaction","enrollment":24},{"nctId":"NCT06105138","phase":"NA","title":"Cannabidiol Effects on Blood Alcohol Level and Intoxication","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2021-03-09","conditions":"Alcohol Use Disorder","enrollment":37},{"nctId":"NCT06542445","phase":"PHASE2","title":"The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD","status":"RECRUITING","sponsor":"Bazelet Nehushtan LtD.","startDate":"2024-08-22","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":120},{"nctId":"NCT03877991","phase":"EARLY_PHASE1","title":"Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2024-02-19","conditions":"Pain","enrollment":12},{"nctId":"NCT05097651","phase":"PHASE2","title":"CBD for Sleep in People With HIV","status":"WITHDRAWN","sponsor":"Mariana Cherner, PhD","startDate":"2021-04-01","conditions":"Sleep Disturbance","enrollment":""},{"nctId":"NCT05232123","phase":"EARLY_PHASE1","title":"Cannabidiol Effects on Cardiovascular System and Exercise Responses","status":"WITHDRAWN","sponsor":"Castleton University","startDate":"2023-07","conditions":"Healthy","enrollment":""},{"nctId":"NCT05892276","phase":"NA","title":"Effects of CBD Oil on Memory Reconsolidation and Trauma-Related Symptoms","status":"WITHDRAWN","sponsor":"University of Texas at Austin","startDate":"2024-08-31","conditions":"Posttraumatic Stress Disorder","enrollment":""},{"nctId":"NCT02783092","phase":"PHASE3","title":"A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy","status":"UNKNOWN","sponsor":"Antonio Waldo Zuardi","startDate":"2019-01-09","conditions":"Epilepsy","enrollment":126},{"nctId":"NCT04831294","phase":"NA","title":"Effects of Cannabidiol (CBD) on the Brain","status":"UNKNOWN","sponsor":"Auburn University","startDate":"2021-07-15","conditions":"CBD, Fear, Inhibition","enrollment":15},{"nctId":"NCT04396730","phase":"PHASE4","title":"Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2020-04-08","conditions":"Contraception","enrollment":9},{"nctId":"NCT04421456","phase":"PHASE2","title":"Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment","status":"TERMINATED","sponsor":"Jazz Pharmaceuticals","startDate":"2020-08-18","conditions":"Schizophrenia","enrollment":95},{"nctId":"NCT04731779","phase":"EARLY_PHASE1","title":"Cannabidiol and Autonomic Function at Rest","status":"COMPLETED","sponsor":"Castleton University","startDate":"2021-08-30","conditions":"Healthy","enrollment":18},{"nctId":"NCT04997954","phase":"PHASE4","title":"EMERALD TRIAL Open Label Extension Study","status":"UNKNOWN","sponsor":"Gold Coast Hospital and Health Service","startDate":"2021-05-17","conditions":"Amyotrophic Lateral Sclerosis, Cannabis, CBD","enrollment":7},{"nctId":"NCT05774574","phase":"NA","title":"Physiological and Appetitive Effects of CBD Supplementation","status":"UNKNOWN","sponsor":"Loughborough University","startDate":"2023-01-20","conditions":"Appetitive Behavior, Adverse Effect, Metabolic Health","enrollment":30},{"nctId":"NCT02607904","phase":"PHASE2","title":"An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-12-15","conditions":"Epilepsy","enrollment":30},{"nctId":"NCT02607891","phase":"PHASE2","title":"A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-11-09","conditions":"Epilepsy","enrollment":35},{"nctId":"NCT01812616","phase":"PHASE1, PHASE2","title":"A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2014-09","conditions":"Cancer","enrollment":21},{"nctId":"NCT01898520","phase":"PHASE3","title":"A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2013-12","conditions":"Cerebral Palsy","enrollment":72},{"nctId":"NCT02565108","phase":"PHASE2","title":"A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-01-20","conditions":"Epilepsy","enrollment":20},{"nctId":"NCT02224690","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2015-04-28","conditions":"Epilepsy, Lennox-Gastaut Syndrome","enrollment":171},{"nctId":"NCT02564952","phase":"PHASE2","title":"An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-03-11","conditions":"Epilepsy","enrollment":18},{"nctId":"NCT02544763","phase":"PHASE3","title":"A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-04-06","conditions":"Tuberous Sclerosis Complex, Seizures","enrollment":224},{"nctId":"NCT02091206","phase":"PHASE2","title":"A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2014-10-22","conditions":"Epilepsy, Dravet Syndrome","enrollment":34},{"nctId":"NCT02091375","phase":"PHASE3","title":"Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2015-03-30","conditions":"Epilepsy, Dravet Syndrome","enrollment":120},{"nctId":"NCT02224703","phase":"PHASE3","title":"GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2015-04-13","conditions":"Epilepsy, Dravet Syndrome","enrollment":199},{"nctId":"NCT02006628","phase":"PHASE2","title":"A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2014-02-25","conditions":"Schizophrenia, Schizophrenia-related Psychotic Disorder","enrollment":88},{"nctId":"NCT02224560","phase":"PHASE3","title":"Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2015-06-08","conditions":"Epilepsy, Lennox Gastaut Syndrome","enrollment":225},{"nctId":"NCT02953548","phase":"PHASE3","title":"Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2017-04-24","conditions":"Infantile Spasms","enrollment":9},{"nctId":"NCT02954887","phase":"PHASE3","title":"Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2017-05-12","conditions":"Infantile Spasms","enrollment":9},{"nctId":"NCT04252586","phase":"PHASE3","title":"A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome","status":"TERMINATED","sponsor":"Jazz Pharmaceuticals","startDate":"2020-02-28","conditions":"Rett Syndrome, RTT","enrollment":21},{"nctId":"NCT02544750","phase":"PHASE3","title":"An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-08-31","conditions":"Tuberous Sclerosis Complex, Seizures","enrollment":199},{"nctId":"NCT04808531","phase":"PHASE3","title":"NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers","status":"UNKNOWN","sponsor":"Medlab Clinical","startDate":"2023-11","conditions":"Cancer Related Pain","enrollment":360},{"nctId":"NCT04726475","phase":"PHASE1, PHASE2","title":"Impact of CBD-Rich Oil on Aversive Memory Reconsolidation","status":"UNKNOWN","sponsor":"University of Texas at Austin","startDate":"2022-01","conditions":"Anxiety and Fear","enrollment":96},{"nctId":"NCT02983695","phase":"PHASE1","title":"Cannabinoid Therapy for Pediatric Epilepsy","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2017-02-02","conditions":"Epilepsy","enrollment":20},{"nctId":"NCT04732169","phase":"PHASE4","title":"Cannabidiol for Treatment Resistant Depression","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2021-07-01","conditions":"Treatment Resistant Depression","enrollment":""},{"nctId":"NCT04790136","phase":"PHASE1","title":"Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration","status":"COMPLETED","sponsor":"SocraTec R&D GmbH","startDate":"2021-03-17","conditions":"Comparative Bioavailability","enrollment":18},{"nctId":"NCT04569760","phase":"PHASE3","title":"Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study","status":"WITHDRAWN","sponsor":"McMaster University","startDate":"2021-04","conditions":"Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder","enrollment":""},{"nctId":"NCT04601207","phase":"PHASE1","title":"A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population","status":"COMPLETED","sponsor":"New Age Ventures LLC","startDate":"2020-06-19","conditions":"Healthy, Cannabis","enrollment":32},{"nctId":"NCT04609748","phase":"PHASE2","title":"Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.","status":"UNKNOWN","sponsor":"Pomeranian Medical University Szczecin","startDate":"2021-01-27","conditions":"Temporomandibular Joint Disorders, Temporomandibular Joint Dysfunction Syndrome, Temporomandibular Joint Pain","enrollment":30},{"nctId":"NCT04059978","phase":"NA","title":"Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy Adults","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-05-26","conditions":"Acute Nociceptive Pain, Hyperalgesia, Allodynia","enrollment":21},{"nctId":"NCT04129489","phase":"PHASE2","title":"A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis","status":"TERMINATED","sponsor":"Stero Biotechs Ltd.","startDate":"2019-02-07","conditions":"Autoimmune Hepatitis","enrollment":2},{"nctId":"NCT04086342","phase":"PHASE2","title":"CHI-902 for Treatment of Social Anxiety Disorder","status":"WITHDRAWN","sponsor":"Canopy Growth Corporation","startDate":"2020-01-24","conditions":"Social Anxiety Disorder","enrollment":""},{"nctId":"NCT02700412","phase":"PHASE1","title":"University of Alabama at Birmingham (UAB) Adult CBD Program","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2015-04","conditions":"Epilepsy, Seizures","enrollment":80},{"nctId":"NCT02695537","phase":"PHASE1","title":"University of Alabama at Birmingham (UAB) Pediatric CBD Program","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2015-04","conditions":"Epilepsy, Seizures","enrollment":89},{"nctId":"NCT02818777","phase":"PHASE2","title":"A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2016-10","conditions":"Parkinson's Disease","enrollment":13},{"nctId":"NCT02956226","phase":"PHASE2","title":"Cannabinoids for Behavioral Problems in Children With ASD","status":"COMPLETED","sponsor":"Shaare Zedek Medical Center","startDate":"2017-01","conditions":"Autistic Disorder","enrollment":150},{"nctId":"NCT01385124","phase":"PHASE1, PHASE2","title":"Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2012-09","conditions":"Graft Versus Host Disease","enrollment":30},{"nctId":"NCT01596075","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2012-07","conditions":"Graft Versus Host Disease","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CBD","Cannabidiol + OCP","CBD 5%"],"phase":"marketed","status":"active","brandName":"Cannabidiol oral oil","genericName":"Cannabidiol oral oil","companyName":"Hôpital le Vinatier","companyId":"h-pital-le-vinatier","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cannabidiol modulates endocannabinoid signaling and multiple other pathways to produce anxiolytic, anti-inflammatory, and neuroprotective effects. Used for Seizure disorders (Dravet syndrome, Lennox-Gastaut syndrome), Anxiety disorders, Epilepsy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}